Literature DB >> 7356741

Improved protein labeling by stannous tartrate reduction of pertechnetate.

W A Pettit, F H DeLand, S J Bennett, D M Goldenberg.   

Abstract

A procedure has been developed whereby small amounts of protein--specifically human serum albumin and immunoglobulin G--can be labeled with Tc-99m. Artifactual problems associated with electrolytic and stannous chloride labeling procedures are virtually eliminated. The procedure is satisfactory for labeling human serum albumin, normal goat immunoglobulin G, and goat anti-carcinoembryonic antigen immunoglobulin G.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356741

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

Review 1.  Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer.

Authors:  A R Fritzberg; R W Berninger; S W Hadley; D W Wester
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

2.  Formation of 99mTc-immunoglobulin G complexes free from radiocolloids, quality controlled by radioimmunoelectrophoresis.

Authors:  E Sundrehagen
Journal:  Eur J Nucl Med       Date:  1982

3.  A Basic ApoE-Based Peptide Mediator to Deliver Proteins across the Blood-Brain Barrier: Long-Term Efficacy, Toxicity, and Mechanism.

Authors:  Yu Meng; Jennifer A Wiseman; Yuliya Nemtsova; Dirk F Moore; Jenieve Guevarra; Kenneth Reuhl; William A Banks; Richard Daneman; David E Sleat; Peter Lobel
Journal:  Mol Ther       Date:  2017-04-26       Impact factor: 11.454

4.  Technetium-99m-labeled antibodies. Stability compared to 125I labeled antibodies.

Authors:  C S Gooden; D E Snook; A A Epenetos
Journal:  Cell Biophys       Date:  1993 Jan-Jun

5.  Amyloid Beta Pathology Exacerbates Weight Loss and Brain Cytokine Responses following Low-Dose Lipopolysaccharide in Aged Female Tg2576 Mice.

Authors:  Rachel C Knopp; Kristen K Baumann; Miranda L Wilson; William A Banks; Michelle A Erickson
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.